ATE528390T1 - Parathyroid- und thymustransplantation bei personen mit di-george-syndrom - Google Patents

Parathyroid- und thymustransplantation bei personen mit di-george-syndrom

Info

Publication number
ATE528390T1
ATE528390T1 AT06739260T AT06739260T ATE528390T1 AT E528390 T1 ATE528390 T1 AT E528390T1 AT 06739260 T AT06739260 T AT 06739260T AT 06739260 T AT06739260 T AT 06739260T AT E528390 T1 ATE528390 T1 AT E528390T1
Authority
AT
Austria
Prior art keywords
parathyroid
thym
transplantation
persons
implanting
Prior art date
Application number
AT06739260T
Other languages
English (en)
Inventor
M Louise Markert
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of ATE528390T1 publication Critical patent/ATE528390T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/065—Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides or bases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06739260T 2005-04-06 2006-03-22 Parathyroid- und thymustransplantation bei personen mit di-george-syndrom ATE528390T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66874505P 2005-04-06 2005-04-06
US70953405P 2005-08-19 2005-08-19
PCT/US2006/010387 WO2006107601A2 (en) 2005-04-06 2006-03-22 Parathyroid and thymus transplantation in digeorge syndrome subjects

Publications (1)

Publication Number Publication Date
ATE528390T1 true ATE528390T1 (de) 2011-10-15

Family

ID=37073935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06739260T ATE528390T1 (de) 2005-04-06 2006-03-22 Parathyroid- und thymustransplantation bei personen mit di-george-syndrom

Country Status (4)

Country Link
US (1) US20090041854A1 (de)
EP (1) EP1866409B1 (de)
AT (1) ATE528390T1 (de)
WO (1) WO2006107601A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8353832B2 (en) * 2008-10-14 2013-01-15 Theraclion Systems and methods for ultrasound treatment of thyroid and parathyroid
JP5431831B2 (ja) * 2009-08-21 2014-03-05 株式会社ディスコ レーザー加工装置
DE102011116280B4 (de) 2011-10-19 2013-05-29 Otto Bock Healthcare Gmbh Verbindungssystem und Prothesensystem
US12364715B2 (en) 2018-02-23 2025-07-22 Enzyvant Therapeutics Gmbh Methods of determining the suitability of cultured thymus tissue for implantation into humans and associated methods of use
US11819520B2 (en) 2018-02-23 2023-11-21 Duke University Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
KR20220044313A (ko) * 2019-08-05 2022-04-07 유니버시티 오브 피츠버그-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 자가 흉선 조직 이식
BR112022003045A2 (pt) * 2019-08-19 2022-05-17 Univ Duke Métodos para determinar a adequação de tecido de timo cultivado para o implante em humanos e métodos de uso associados

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035039A1 (en) * 1997-02-06 1998-08-13 Human Genome Sciences, Inc. Dendritic cell-derived growth factor

Also Published As

Publication number Publication date
EP1866409A4 (de) 2010-01-06
EP1866409A2 (de) 2007-12-19
US20090041854A1 (en) 2009-02-12
EP1866409B1 (de) 2011-10-12
WO2006107601A3 (en) 2007-03-15
WO2006107601A2 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
DE602005026638D1 (de) Gerät zur behandlung von organvorfall im weiblichen becken
TW200637574A (en) Treatment method
MX2010009724A (es) Procedimientos de tratamiento del dolor inflamatorio-.
WO2004034890A3 (en) Biological scaffolding material
WO2008042174A3 (en) Mesenchymal stem cells and uses therefor
WO2005091933A3 (en) Skin treatment method with lactobacillus extract
UA91521C2 (ru) Композиции, содержащие липазу, протеазу и амилазу, предназначенные для лечения недостаточности поджелудочной железы
TW200637522A (en) Skin treatment articles and methods
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
EA201290027A1 (ru) Ацилированные аналоги глюкагона
MY160041A (en) Compositions and methods for treating parasitic infections
NZ630187A (en) Smooth muscle cell constructs
WO2009079451A3 (en) Compositions and methods of promoting wound healing
EA200700965A1 (ru) Трегалоза и/или изомальтулоза в качестве носителя для сухой ароматической композиции
WO2008101566A3 (de) Verfahren zur behandlung biologischer gewebe tierischen oder menschlichen ursprungs wie schweine-, rinderperikard- oder menschlicher leichen-herzklappen sowie entsprechend behandeltes biologisches gewebe
ATE485832T1 (de) Glucoseisomerase zur behandlung von fructose- unverträglichkeit
ATE464056T1 (de) Verfahren zur aktivierung von nkt-zellen
WO2006107601A3 (en) Parathyroid and thymus transplantation in digeorge syndrome subjects
ZA200703441B (en) Coadministration of tigecycline and digoxin
CL2011000248A1 (es) Metodo para aumentar el crecimiento o diferenciacion in vitro en un cultivo de celulas o tejido, basado en la aplicacion de radio frecuencia pulsada (prf); y uso de dicho tratamiento.
WO2005102363A3 (en) Methods of promoting cartilage healing or cartilage integration
ATE421330T1 (de) Flüssige allergie-impfstoffformulierung zur oromukosalen verabreichung
WO2005077046A3 (en) A composition and method of treating mastitis
WO2007112173A8 (en) Method for promoting composite tissue regeneration and uses thereof
TW200640484A (en) Treatment of brain tissue damage

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties